CO-RM/NSAID molecular hybrids: a promising alliance to overcome limitations and enhance the anti-inflammatory and chemopreventive activities of a widespread used drug class
cun id:
312
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma